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The frequency of typical and atypical Beijing strains of 
Mycobacterium tuberculosis was determined in the Nether-
lands; Vietnam; and Hong Kong Special Administrative Re-
gion, People’s Republic of China. The strains’ associations 
with drug resistance, M. bovis BCG vaccination, and patient 
characteristics were assessed. BCG vaccination may have 
positively selected the prevalent typical Beijing strains.
M
ycobacterium tuberculosis Beijing strains cause a 
substantial proportion of tuberculosis (TB) cases 
worldwide (1). Experiments in a BALB/c mouse model (2) 
and a rabbit model (3) supported the hypothesis that Beijing 
strains might represent “escape variants” of M. bovis BCG 
vaccination (4). In a study in Ho Chi Minh City, Vietnam, 
presence of a BCG scar correlated, but not signiﬁ  cantly, 
with infection by Beijing strains (5).
The Beijing clade is highly prevalent in Asia, where 
the proportion of TB cases caused by strains of this clade 
usually is stable over time, and no association with drug 
resistance has been recorded. In other areas (e.g., Cuba, 
South Africa, countries of the former Soviet Union, and 
Vietnam), Beijing strains are emerging and associated with 
resistance to anti-TB drugs (1). The Beijing clade compris-
es at least 2 major subgroups, which share the characteris-
tic spoligotype pattern (6–8): typical and atypical Beijing 
strains. Typical (“modern” [8,9]) Beijing strains, including 
W strains (7), exhibit highly similar, multicopy insertion 
sequence (IS) 6110 restriction fragment length polymor-
phism (RFLP) patterns and have alterations in putative 
mutator genes (4,10). Atypical (“ancestral” [8,9]) Beijing 
strains more closely resemble the common ancestor of the 
Beijing clade (6–8,10). The ability of these Beijing clade 
subgroups to gain resistance or circumvent BCG vaccine–
induced immunity may differ and thus explain the differ-
ences in geographic distribution of Beijing strains and the 
variation in association with drug resistance. However, few 
studies have distinguished between subgroups of the Bei-
jing clade, or studies were limited in the number of strains 
analyzed (8,9,11,12).
The Study
We used 3 large data sets from previously described 
studies to investigate possible differences in correlation 
with resistance and BCG vaccination between sublineages 
of the Beijing clade. Details about drug-susceptibility test-
ing, DNA ﬁ  ngerprinting, and demographics by origin can 
be found elsewhere (5,13,14). In the Netherlands, 415 (6%) 
of 6,829 M. tuberculosis isolates with available IS6110 
RFLP patterns from 1993 through 2000 were of the Beijing 
clade (13); approximately one third of cases each originat-
ed in the Netherlands and Asia and the remaining one third 
in other areas (13). In Vietnam, 301 (53%) of 563 isolates 
from new TB cases, collected during 1998–1999 mainly 
in Ho Chi Minh City, belonged to the Beijing clade (5). 
In Hong Kong Special Administrative Region, People’s 
Republic of China, 355 (71%) of 500 randomly selected 
M. tuberculosis isolates collected during 1998–1999 from 
patients before treatment were of the Beijing clade (14). In-
formation about patient sex and age was available from all 
3 sites. Drug susceptibility data and BCG status of patients 
(presence/absence of BCG scar) were not available from 
Hong Kong. The patients in this study were treated accord-
ing to World Health Organization guidelines, independent 
from their M. tuberculosis isolates’ genotype.
Beijing clade strains were deﬁ  ned by their spoligotype 
pattern (6). We used the multiplex PCR of Plikaytis et al. 
(15) to differentiate 3 subgroups of the Beijing clade (W 
strain, typical, atypical). A speciﬁ  c IS6110 insertion in the 
NTF region is detected in typical Beijing strains (7). W 
strains, a subgroup of typical Beijing strains, contain this 
IS6110 and an additional IS6110 insertion in this region 
(7,15). Figure 1 shows the correlation between the multi-
plex PCR results and IS6110 RFLP similarity.
A total of 1,023 M. tuberculosis Beijing clade iso-
lates (410 from the Netherlands, 268 from Vietnam, and 
345 from Hong Kong) were available for multiplex PCR 
analysis. Mean age category of patients was 25–34 years, 
and >75% were <45 years of age. Because the W strain 
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typical Beijing strain.
Typical and atypical subgroups were equally distrib-
uted among men and women but varied by country and 
patient age. Atypical Beijing strains occurred in 25.4% 
(68/268) of isolates in Vietnam, 21.2% (87/410) in the 
Netherlands, and 13.6% (47/345) in Hong Kong. Atypical 
Beijing strains were encountered less frequently in Hong 
Kong than in Vietnam (p<0.001) and the Netherlands (p 
= 0.007). The Beijing subgroups were equally prevalent 
among persons of different age groups in Hong Kong, but 
atypical Beijing strains occurred more frequently in older 
persons in the Netherlands and Vietnam (Figure 2). This in-
crease in proportion of atypical Beijing strains in older per-
sons was signiﬁ  cant in the Netherlands (χ2
trend 4.5, p<0.035). 
Combined data for the Netherlands and Vietnam showed 
signiﬁ  cantly more atypical Beijing isolates among patients 
>75 years of age (odds ratio [OR] 2.96, 95% conﬁ  dence 
interval [CI] 1.15–7.67) (Table 1), which suggests more 
recent introduction and spread of typical Beijing strains.
To determine whether BCG vaccination might drive 
this shift in prevalence of the 2 Beijing subgroups, we 
investigated their distribution in persons vaccinated and 
not vaccinated with BCG. Of 249 nonvaccinated persons, 
27.7% were infected with atypical strains; of 265 vacci-
nated persons, a signiﬁ   cantly lower proportion (20.8%) 
were infected with atypical strains (adjusted OR 0.60, 95% 
CI 0.38–0.95) (Table 1). The proportions per genotype em-
phasized this ﬁ  nding; 44.4% of atypical Beijing strains and 
53.8% of typical Beijing strains were isolated from vac-
cinated persons. The association between typical Beijing 
strains and vaccination was strong in the data from the 
Netherlands: 14.2% of Beijing strains isolated from vac-
cinated persons and 31% of those from nonvaccinated per-
sons were atypical (adjusted OR 0.39, 95% CI 0.20–0.76). 
In Vietnam, the proportions were nonsigniﬁ  cant (26.2% 
and 24.4%, respectively).
The unknown BCG vaccination status of 164 of 678 
Beijing strain–infected patients is a limitation of our study. 
In these patients (from the Netherlands), the proportion of 
atypical Beijing strains was lower and almost similar to 
that for vaccinated patients. Therefore, if all patients with 
unknown BCG status were considered nonvaccinated, the 
association with typical Beijing strains and BCG vaccina-
tion would disappear. However, the Netherlands’ National 
Tuberculosis Register most likely lacks BCG status data 
because the BCG status for these patients was not checked; 
we assume the absence of these data introduced no bias. 
To investigate this further, we extended the analysis of 
the population in the Netherlands by including all patients 
with known BCG status (n = 4,004). The proportions of 
typical Beijing strains for BCG-vaccinated and BCG-
nonvaccinated persons were 54.2% and 45.8%, respec-
tively. For all strains other than Beijing strains (i.e., atypi-
cal Beijing strains and M. tuberculosis strains of all other 
genotypes), these proportions were 44.5% and 55.5%, re-
spectively. Thus, including all isolates from persons with 
known BCG status, typical Beijing strains still were iso-
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Figure 1. Correlation between the multiplex PCR results and insertion 
sequence (IS)6110 restriction fragment length polymorphism (RFLP) 
pattern similarity. On the basis of IS6110 RFLP pattern similarity, 3 
groups of related patterns (A, B, and C) were recognized among 
410 Mycobacterium tuberculosis Beijing clade strains isolated in the 
Netherlands. The similarity of the IS6110 RFLP patterns of groups 
B (61%–73%) and C (50%) are relative to the RFLP patterns of 
group A. Within group C, the similarity of the patterns was at least 
58%. By using an IS6110 RFLP similarity of 73% as cutoff (which 
deﬁ   ned the most homogeneous IS6110 RFLP group [group A]), 
321 (98.2%) of 327 Beijing strains were consistently identiﬁ  ed as 
typical Beijing, and 81 (97.6%) of the 83 remaining Beijing clade 
strains were classiﬁ  ed as atypical Beijing by the multiplex PCR. The 
κ value for agreement between the tests is 0.922.
Figure 2. Proportion of atypical Beijing strains among persons with 
Mycobacterium tuberculosis Beijing clade strains in Vietnam, the 
Netherlands, and Hong Kong, by patient age. The data point of the 
>75-year age category from the data from Vietnam was omitted 
because the group contained only 1 patient.Mycobacterium tuberculosis Beijing Strains
lated signiﬁ  cantly more often from BCG-vaccinated than 
BCG-nonvaccinated persons (p = 0.008). Our ﬁ  ndings of 
signiﬁ  cantly fewer typical Beijing isolates among patients 
>75 years of age (mostly experiencing reactivation and 
thus representing the population structure of M. tubercu-
losis of decades ago) and signiﬁ  cantly more isolates of 
typical Beijing strains from BCG-vaccinated persons sup-
port the hypothesis that BCG vaccination might favor the 
spread of the typical Beijing strains.
Drug resistance of M. tuberculosis Beijing subgroups 
varied by country (Table 2). In Vietnam, drug resistance 
was signiﬁ  cantly higher than in the Netherlands; 6.7% 
of Beijing strains in Vietnam compared with 2.0% in 
the Netherlands were multidrug resistant (MDR), 32.1% 
compared with 11.0% were isoniazid (INH) resistant, and 
44.0% compared with 15.9% were streptomycin resis-
tant (Table 2). Atypical Beijing isolates were more often 
INH resistant (25.2%) than were typical Beijing isolates 
(17.6%). Furthermore, atypical Beijing strains were more 
often MDR (7.1%, compared with 2.9%). Atypical Bei-
jing strains were less often streptomycin resistant (21.3% 
compared with 28.7%) (Table 2). Thus, atypical Beijing 
isolates were associated with INH resistance and MDR 
and signiﬁ  cantly less likely to be streptomycin resistant 
than typical Beijing isolates. Similar differences in drug 
resistance recently were found for the 2 Beijing subgroups 
among isolates circulating in Japan (12) and in the Beijing 
region of China (9), but the ﬁ  ndings in China were not 
statistically signiﬁ  cant, probably because of the limited 
number of stains analyzed. These differences in drug re-
sistance associations suggest the different Beijing sublin-
eages might have different mechanisms of drug resistance 
development.
Despite the association of atypical Beijing strains with 
INH and multidrug resistance found in this study, typical 
Beijing strains contribute most substantially to the world-
wide MDR TB epidemic (1,4,11). However, in studies 
showing an association between typical Beijing strains and 
multidrug resistance, these strains usually also were resis-
tant to streptomycin (as we also found). Typical Beijing 
strains may therefore become streptomycin resistant more 
easily, eventually leading to MDR TB, as the W-strain 
outbreak in New York showed (16). Alternatively, the in-
creased prevalence of typical Beijing strains in the current 
global M. tuberculosis population may be caused not by 
drug-driven selection but by their hypervirulence (2), high-
er adaptability (10), higher rate of progression to disease, 
greater ability to circumvent BCG-induced immunity (2,3, 
this study), or other speciﬁ  c features.
Conclusions
We showed that subgroups of the M. tuberculosis Bei-
jing clade have different associations with drug resistance 
and BCG vaccination. Individual lineages of the Beijing 
clade are likely to be evolving in different areas, possibly 
because of intrinsic strain characteristics, differences in 
anti-TB drug regimens and BCG-vaccination strategies in 
different areas, chance, or a combination of these. Thus, 
anti-TB drugs and BCG vaccination inﬂ  uence the dynam-
ics in the population structure of M. tuberculosis. The 
efﬁ  cacy of new candidate TB vaccines therefore should 
be tested against a broad panel of epidemic strains from 
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Table 1. Risk factors for atypical Mycobacterium tuberculosis in 678 Beijing strain–infected persons with tuberculosis, Vietnam and the 
Netherlands
Odds ratio (95% confidence interval) 
Risk factor 
Total no. patients infected 
with Beijing clade 
No. (%) patients infected with 
atypical Beijing strain  Crude Adjusted*
Country 
 Vietnam  268 68  (25.4)  1 1
  The Netherlands  410 87 (21.2)  0.79 (0.55–1.14)  0.82 (0.52–1.29) 
Sex 
 M  415 93  (22.4)  1 1
  F  219 48 (21.9)  0.97 (0.66–1.44)  1.01 (0.67–1.51) 
  Unknown  44 14 (31.8)  1.62 (0.82–3.17)  1.92 (0.90–4.11) 
Age, y 
 <25  164 36  (22.0)  1 1
  25–34  215 51 (23.7)  1.11 (0.68–1.80)  1.05 (0.64–1.73) 
  35–44  140 29 (20.7)  0.93 (0.54–1.61)  0.80 (0.45–1.42) 
  45–54  51 7 (13.7)  0.57 (0.24–1.36)  0.45 (0.18–1.12) 
  55–64  36 9 (25.0)  1.19 (0.51–2.75)  1.03 (0.44–2.45) 
  65–74  50 13 (26.0)  1.25 (0.60–2.60)  1.07 (0.50–2.30) 
>75 22 10 (45.5)  2.96 (1.18–7.41)  2.96 (1.15–7.67) 
BCG† vaccination 
 No  249 69  (27.7)  1 1
  Yes  265 55 (20.8)  0.68 (0.46–1.03)  0.60 (0.38–0.95) 
  Unknown  164 31 (18.9)  0.61 (0.38–0.98)  0.61 (0.36–1.04) 
Total 678 155 (22.8) 
*Adjusted for country, sex, age group, and BCG vaccination. 
†BCG, Mycobacterium bovis bacillus Calmette-Guérin. all high-prevalence areas (4). Furthermore, treatment of 
infections by different M. tuberculosis genotypes might 
require different anti-TB treatment strategies. More ex-
tended studies are needed in high-prevalence settings, es-
pecially studies of other predominant genotype families of 
M. tuberculosis.
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